Literature DB >> 26610419

The Challenge of Global Poliomyelitis Eradication.

Julie R Garon1, Stephen L Cochi2, Walter A Orenstein3.   

Abstract

In the United States during the 1950's, polio was on the forefront of every provider and caregiver's mind. Today, most providers in the United States have never seen a case. The Global Polio Eradication Initiative (GPEI), which began in 1988 has reduced the number of cases by over 99%. The world is closer to achieving global eradication of polio than ever before but as long as poliovirus circulates anywhere in the world, every country is vulnerable. The global community can support the polio eradication effort through continued vaccination, surveillance, enforcing travel regulations and contributing financial support, partnerships and advocacy.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Eradication; Inactivated poliovirus vaccine (IPV); Oral poliovirus vaccine (OPV); Poliomyelitis

Mesh:

Substances:

Year:  2015        PMID: 26610419     DOI: 10.1016/j.idc.2015.07.003

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  9 in total

Review 1.  The pathogenesis and virulence of enterovirus-D68 infection.

Authors:  Syriam Sooksawasdi Na Ayudhya; Brigitta M Laksono; Debby van Riel
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

Review 2.  Treatment of perinatal viral infections to improve neurologic outcomes.

Authors:  William J Muller
Journal:  Pediatr Res       Date:  2016-09-27       Impact factor: 3.756

3.  Serological Monitoring Is Key To Sustain Progress of the Maternal and Neonatal Tetanus Elimination Initiative.

Authors:  Myron M Levine; Marcela F Pasetti
Journal:  Clin Vaccine Immunol       Date:  2016-07-05

4.  Effect of chiropractic treatment on primary or early secondary prevention: a systematic review with a pedagogic approach.

Authors:  Guillaume Goncalves; Christine Le Scanff; Charlotte Leboeuf-Yde
Journal:  Chiropr Man Therap       Date:  2018-04-05

5.  Post-immunization leucocytosis and its implications for the management of febrile infants.

Authors:  Sarah Prentice; Zephyrian Kamushaaga; Stephen B Nash; Alison M Elliott; Hazel M Dockrell; Stephen Cose
Journal:  Vaccine       Date:  2018-04-11       Impact factor: 3.641

6.  Combinatorial Approaches to Viral Attenuation.

Authors:  Matthew L Paff; Benjamin R Jack; Bartram L Smith; James J Bull; Claus O Wilke
Journal:  mSystems       Date:  2018-07-31       Impact factor: 6.496

7.  A novel gamma radiation-inactivated sabin-based polio vaccine.

Authors:  Gregory J Tobin; John K Tobin; Elena K Gaidamakova; Taralyn J Wiggins; Ruth V Bushnell; Wai-Ming Lee; Vera Y Matrosova; Stephen J Dollery; Heather N Meeks; Diana Kouiavskaia; Konstantin Chumakov; Michael J Daly
Journal:  PLoS One       Date:  2020-01-30       Impact factor: 3.240

8.  The detection of 3 ambiguous type 2 vaccine-derived polioviruses (VDPV2s) in Uganda.

Authors:  Mary Bridget Nanteza; Barnabas Bakamutumaho; Annet Kisakye; Prossy Namuwulya; Henry Bukenya; Edson Katushabe; Josephine Bwogi; Charles Rutebarika Byabamazima; Raffaella Williams; Nicksy Gumede
Journal:  Virol J       Date:  2018-04-27       Impact factor: 4.099

9.  MicroRNA-134 regulates poliovirus replication by IRES targeting.

Authors:  Abhijeet A Bakre; Byoung-Shik Shim; Ralph A Tripp
Journal:  Sci Rep       Date:  2017-10-04       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.